vs
Side-by-side financial comparison of Hyatt Hotels Corp (H) and HAEMONETICS CORP (HAE). Click either name above to swap in a different company.
Hyatt Hotels Corp is the larger business by last-quarter revenue ($1.8B vs $1.3B, roughly 1.3× HAEMONETICS CORP). HAEMONETICS CORP runs the higher net margin — 7.3% vs -1.1%, a 8.4% gap on every dollar of revenue. On growth, Hyatt Hotels Corp posted the faster year-over-year revenue change (11.7% vs 4.8%). Hyatt Hotels Corp produced more free cash flow last quarter ($236.0M vs $209.9M). Over the past eight quarters, HAEMONETICS CORP's revenue compounded faster (99.2% CAGR vs 2.2%).
Hyatt Hotels Corporation, commonly known as Hyatt Hotels & Resorts, is an American multinational hospitality company headquartered in the Riverside Plaza area of Chicago that manages and franchises luxury and business hotels, resorts, and vacation properties. Hyatt Hotels & Resorts is one of the businesses managed by the Pritzker family. Hyatt has more than 1350 hotels and all-inclusive properties in 69 countries, across North America, South America, Europe, Asia, Africa and Australia.
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
H vs HAE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.8B | $1.3B |
| Net Profit | $-20.0M | $97.3M |
| Gross Margin | — | 14.9% |
| Operating Margin | 0.4% | 83.4% |
| Net Margin | -1.1% | 7.3% |
| Revenue YoY | 11.7% | 4.8% |
| Net Profit YoY | 64.3% | -42.0% |
| EPS (diluted) | $-0.20 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.3B | ||
| Q4 25 | $1.8B | $339.0M | ||
| Q3 25 | $1.8B | $327.3M | ||
| Q2 25 | $1.8B | $321.4M | ||
| Q1 25 | $1.7B | $330.6M | ||
| Q4 24 | $1.6B | $348.5M | ||
| Q3 24 | $1.6B | $345.5M | ||
| Q2 24 | $1.7B | $336.2M |
| Q1 26 | — | $97.3M | ||
| Q4 25 | $-20.0M | $44.7M | ||
| Q3 25 | $-49.0M | $38.7M | ||
| Q2 25 | $-3.0M | $34.0M | ||
| Q1 25 | $20.0M | $58.0M | ||
| Q4 24 | $-56.0M | $37.5M | ||
| Q3 24 | $471.0M | $33.8M | ||
| Q2 24 | $359.0M | $38.4M |
| Q1 26 | — | 14.9% | ||
| Q4 25 | — | 59.7% | ||
| Q3 25 | — | 59.5% | ||
| Q2 25 | — | 59.8% | ||
| Q1 25 | — | 58.4% | ||
| Q4 24 | — | 55.5% | ||
| Q3 24 | — | 54.2% | ||
| Q2 24 | — | 52.0% |
| Q1 26 | — | 83.4% | ||
| Q4 25 | 0.4% | 19.9% | ||
| Q3 25 | -1.0% | 17.9% | ||
| Q2 25 | 2.1% | 16.8% | ||
| Q1 25 | 3.0% | 21.6% | ||
| Q4 24 | -3.0% | 16.9% | ||
| Q3 24 | 37.3% | 15.0% | ||
| Q2 24 | 27.1% | 11.8% |
| Q1 26 | — | 7.3% | ||
| Q4 25 | -1.1% | 13.2% | ||
| Q3 25 | -2.7% | 11.8% | ||
| Q2 25 | -0.2% | 10.6% | ||
| Q1 25 | 1.2% | 17.5% | ||
| Q4 24 | -3.5% | 10.8% | ||
| Q3 24 | 28.9% | 9.8% | ||
| Q2 24 | 21.1% | 11.4% |
| Q1 26 | — | — | ||
| Q4 25 | $-0.20 | $0.95 | ||
| Q3 25 | $-0.51 | $0.81 | ||
| Q2 25 | $-0.03 | $0.70 | ||
| Q1 25 | $0.19 | $1.17 | ||
| Q4 24 | $-0.37 | $0.74 | ||
| Q3 24 | $4.63 | $0.66 | ||
| Q2 24 | $3.46 | $0.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $813.0M | $245.4M |
| Total DebtLower is stronger | — | $1.2B |
| Stockholders' EquityBook value | $3.3B | $796.3M |
| Total Assets | $14.0B | $2.4B |
| Debt / EquityLower = less leverage | — | 1.53× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.4M | ||
| Q4 25 | $813.0M | $363.4M | ||
| Q3 25 | $749.0M | $296.4M | ||
| Q2 25 | $912.0M | $292.9M | ||
| Q1 25 | $1.8B | $306.8M | ||
| Q4 24 | $1.4B | $320.8M | ||
| Q3 24 | $1.1B | $299.3M | ||
| Q2 24 | $2.0B | $344.4M |
| Q1 26 | — | $1.2B | ||
| Q4 25 | — | $1.2B | ||
| Q3 25 | $6.0B | $1.2B | ||
| Q2 25 | $6.0B | $1.2B | ||
| Q1 25 | $4.3B | $1.2B | ||
| Q4 24 | $3.8B | — | ||
| Q3 24 | $3.1B | — | ||
| Q2 24 | $3.9B | — |
| Q1 26 | — | $796.3M | ||
| Q4 25 | $3.3B | $911.5M | ||
| Q3 25 | $3.5B | $849.2M | ||
| Q2 25 | $3.6B | $882.3M | ||
| Q1 25 | $3.5B | $820.8M | ||
| Q4 24 | $3.5B | $906.9M | ||
| Q3 24 | $3.7B | $878.9M | ||
| Q2 24 | $3.9B | $905.4M |
| Q1 26 | — | $2.4B | ||
| Q4 25 | $14.0B | $2.5B | ||
| Q3 25 | $15.7B | $2.4B | ||
| Q2 25 | $15.9B | $2.5B | ||
| Q1 25 | $14.0B | $2.5B | ||
| Q4 24 | $13.3B | $2.5B | ||
| Q3 24 | $11.9B | $2.5B | ||
| Q2 24 | $12.8B | $2.5B |
| Q1 26 | — | 1.53× | ||
| Q4 25 | — | 1.34× | ||
| Q3 25 | 1.73× | 1.44× | ||
| Q2 25 | 1.69× | 1.39× | ||
| Q1 25 | 1.25× | 1.49× | ||
| Q4 24 | 1.07× | — | ||
| Q3 24 | 0.85× | — | ||
| Q2 24 | 1.01× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $313.0M | $293.2M |
| Free Cash FlowOCF − Capex | $236.0M | $209.9M |
| FCF MarginFCF / Revenue | 13.2% | 15.7% |
| Capex IntensityCapex / Revenue | 4.3% | 2.5% |
| Cash ConversionOCF / Net Profit | — | 3.01× |
| TTM Free Cash FlowTrailing 4 quarters | $159.0M | $417.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $293.2M | ||
| Q4 25 | $313.0M | $93.6M | ||
| Q3 25 | $-20.0M | $111.3M | ||
| Q2 25 | $-67.0M | $17.4M | ||
| Q1 25 | $153.0M | $116.6M | ||
| Q4 24 | $235.0M | $43.8M | ||
| Q3 24 | $-21.0M | $48.8M | ||
| Q2 24 | $177.0M | $-27.4M |
| Q1 26 | — | $209.9M | ||
| Q4 25 | $236.0M | $87.2M | ||
| Q3 25 | $-89.0M | $106.3M | ||
| Q2 25 | $-111.0M | $13.6M | ||
| Q1 25 | $123.0M | $100.9M | ||
| Q4 24 | $184.0M | $35.2M | ||
| Q3 24 | $-64.0M | $39.4M | ||
| Q2 24 | $135.0M | $-33.1M |
| Q1 26 | — | 15.7% | ||
| Q4 25 | 13.2% | 25.7% | ||
| Q3 25 | -5.0% | 32.5% | ||
| Q2 25 | -6.1% | 4.2% | ||
| Q1 25 | 7.2% | 30.5% | ||
| Q4 24 | 11.5% | 10.1% | ||
| Q3 24 | -3.9% | 11.4% | ||
| Q2 24 | 7.9% | -9.8% |
| Q1 26 | — | 2.5% | ||
| Q4 25 | 4.3% | 1.9% | ||
| Q3 25 | 3.9% | 1.5% | ||
| Q2 25 | 2.4% | 1.2% | ||
| Q1 25 | 1.7% | 4.7% | ||
| Q4 24 | 3.2% | 2.5% | ||
| Q3 24 | 2.6% | 2.7% | ||
| Q2 24 | 2.5% | 1.7% |
| Q1 26 | — | 3.01× | ||
| Q4 25 | — | 2.09× | ||
| Q3 25 | — | 2.88× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | 7.65× | 2.01× | ||
| Q4 24 | — | 1.17× | ||
| Q3 24 | -0.04× | 1.44× | ||
| Q2 24 | 0.49× | -0.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
H
| Other | $627.0M | 35% |
| Rooms Revenue | $326.0M | 18% |
| Net Fees | $290.0M | 16% |
| Distribution Segment | $177.0M | 10% |
| Franchise And Other Fees | $114.0M | 6% |
| Base Management Fees | $112.0M | 6% |
| Incentive Management Fees | $81.0M | 5% |
| Other Owned And Leased Hotel Revenue | $41.0M | 2% |
| Contra Revenue | $17.0M | 1% |
| Other Revenues | $4.0M | 0% |
HAE
Segment breakdown not available.
